These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2161088)

  • 1. A mechanism additional to cyclic AMP accumulation for vasoactive intestinal peptide-induced prolactin release.
    Pizzi M; Memo M; Benarese M; Simonazzi E; Missale C; Spano PF
    Neuroendocrinology; 1990 Apr; 51(4):481-6. PubMed ID: 2161088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pertussis toxin blocks both cyclic AMP-mediated and cyclic AMP-independent actions of somatostatin. Evidence for coupling of Ni to decreases in intracellular free calcium.
    Koch BD; Dorflinger LJ; Schonbrunn A
    J Biol Chem; 1985 Oct; 260(24):13138-45. PubMed ID: 2865257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct effect of adenosine on prolactin secretion at the level of the single rat lactotroph: involvement of pertussis toxin-sensitive and -insensitive transducing mechanisms.
    Scorziello A; Landolfi E; Grimaldi M; Meucci O; Ventra C; Avallone A; Postiglione A; Schettini G
    J Mol Endocrinol; 1993 Dec; 11(3):325-34. PubMed ID: 8148040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of vasoactive intestinal peptide-releasing property in prolactin cells from ovariectomized rats: contribution of post-transductional impairments.
    Pizzi M; Arrighi V; Galli P; Memo M; Spano PF
    Eur J Endocrinol; 1994 Apr; 130(4):361-5. PubMed ID: 8162165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive intestinal peptide and peptide with N-terminal histidine and C-terminal isoleucine increase prolactin secretion in cultured rat pituitary cells (GH4C1) via a cAMP-dependent mechanism which involves transient elevation of intracellular Ca2+.
    Bjøro T; Ostberg BC; Sand O; Gordeladze J; Iversen JG; Torjesen PA; Gautvik KM; Haug E
    Mol Cell Endocrinol; 1987 Feb; 49(2-3):119-28. PubMed ID: 2435588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion.
    Balsa JA; Sánchez-Franco F; Lorenzo MJ; Pazos F; Lara JI; Cacicedo L
    Endocrinology; 1996 Feb; 137(2):508-13. PubMed ID: 8593796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biphasic action of forskolin on growth hormone and prolactin secretion by rat anterior pituitary cells in vitro.
    Szabo M; Staib NE; Collins BJ; Cuttler L
    Endocrinology; 1990 Oct; 127(4):1811-7. PubMed ID: 1698147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pertussis toxin blocks the inhibitory effects of somatostatin on cAMP-dependent vasoactive intestinal peptide and cAMP-independent thyrotropin releasing hormone-stimulated prolactin secretion of GH3 cells.
    Yajima Y; Akita Y; Saito T
    J Biol Chem; 1986 Feb; 261(6):2684-9. PubMed ID: 2869031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin inhibits prolactin secretion by multiple mechanisms involving a site of action distal to increased cyclic adenosine 3',5'-monophosphate and elevated cytosolic Ca2+ in rat lactotrophs.
    Bjøro T; Ostberg BC; Sand O; Torjesen PA; Penman E; Gordeladze JO; Iversen JG; Gautvik KM; Haug E
    Acta Physiol Scand; 1988 Jul; 133(3):271-82. PubMed ID: 2906508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
    Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
    Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of vasoactive intestinal peptide and 5-HT2 receptor subtype in serotonin stimulation of basal and thyrotropin-releasing-hormone-induced prolactin release in vitro from rat pituitary cells.
    Apfelbaum ME
    Neuroendocrinology; 1998 Jan; 67(1):45-50. PubMed ID: 9485168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal interactions of somatostatin with thyrotropin-releasing hormone and vasoactive intestinal peptide on prolactin and growth hormone secretion in vitro.
    Enjalbert A; Epelbaum J; Arancibia S; Tapia-Arancibia L; Bluet-Pajot MT; Kordon C
    Endocrinology; 1982 Jul; 111(1):42-7. PubMed ID: 6123432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mastoparan-stimulated prolactin secretion in rat pituitary GH3 cells involves activation of Gq/11 proteins.
    Yajima Y; Uchino K; Ito H; Kawashima S
    Endocrinology; 1997 May; 138(5):1949-58. PubMed ID: 9112392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient removal of dopamine potentiates the stimulation of prolactin release by TRH but not VIP: stimulation via Ca2+/protein kinase C pathway.
    Martínez de la Escalera G; Guthrie J; Weiner RI
    Neuroendocrinology; 1988 Jan; 47(1):38-45. PubMed ID: 3124014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of the adenosine 3',5'-monophosphate and the Ca2+ messenger systems together reverse dopaminergic inhibition of prolactin release.
    Delbeke D; Dannies PS
    Endocrinology; 1985 Aug; 117(2):439-46. PubMed ID: 2990850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dependence of electrical activity and calcium influx-controlled prolactin release on adenylyl cyclase signaling pathway in pituitary lactotrophs.
    Gonzalez-Iglesias AE; Jiang Y; Tomić M; Kretschmannova K; Andric SA; Zemkova H; Stojilkovic SS
    Mol Endocrinol; 2006 Sep; 20(9):2231-46. PubMed ID: 16645040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GnRH-associated peptide decreases cyclic AMP accumulation in the GH3 pituitary cell line.
    Vân Chuoï MT; Vacher P; Dufy B
    Neuroendocrinology; 1993 Aug; 58(2):251-7. PubMed ID: 8264871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanisms by which vasoactive intestinal peptide (VIP) and thyrotropin releasing hormone (TRH) stimulate prolactin release from pituitary cells.
    Bjøro T; Sand O; Ostberg BC; Gordeladze JO; Torjesen P; Gautvik KM; Haug E
    Biosci Rep; 1990 Apr; 10(2):189-99. PubMed ID: 2162702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
    Dorflinger LJ; Schonbrunn A
    Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium ions: their role and mechanism of action in the control of prolactin release.
    Collu R; Lafond J; Marchisio AM; Eljarmak D; Ducharme JR
    Endocrinology; 1984 Apr; 114(4):1302-7. PubMed ID: 6423371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.